Kiora Pharmaceuticals Inc. - KPRX Net earnings per one share for the last twelve months

Public company logo of Kiora Pharma (KPRX)

Kiora Pharmaceuticals (KPRX) operates within a stable US legal framework, free from external political threats. Funding for the development of treatments for rare ocular pathologies relies on investment capital. Net income per share growth YoY over the last 12 months reflects a trend where -19.20 represents the latest level. The business creates a unique biopharmaceutical environment by utilizing patented KIO-301 light-sensitive molecules for the long-term treatment of patients.

KPRX Kiora Pharmaceuticals: Earnings per share for the last twelve months in the range 02/11/2024 - 11/17/2026

KPRX (Kiora Pharma): analytical breakdowns and indicator data

Initial company analysis:Kiora Pharmaceuticals Inc. KPRX
Original product of Kiora Pharmaceuticals Inc.

The development dynamics of retinal drugs are directly reflected in the comparable year-over-year growth of EPS TTM for Kiora Pharmaceuticals (KPRX). This indicator measures the percentage change in earnings per share over the last twelve months, neutralizing short-term volatility. The metric reveals the impact of one-time fiscal factors on net income. This is critical for Kiora Pharmaceuticals (KPRX), as the current scaling of tests is increasing unit costs. The stability of this indicator confirms the fundamental resilience of the assets.

Competitor analysis for Kiora Pharmaceuticals

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocular Pharma (OCUL)|HROW (Harrow) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VRDN (Viridian Corp)|LENZ Corp (LENZ) - Net earnings per one share for the last twelve months|OCS: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months eyepointpharma.com|KOD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aldeyra Therapeutics (ALDX)|Net earnings per share for the last 12 months KALA|IRD - Net earnings per share for the trailing year|Earnings per share for the last twelve months okyopharma.com (OKYO)|Net earnings per share (EPS TTM) Adverum Biotechnologies Inc. (ADVM)|Earnings per share for the last twelve months outlooktherapeutics.com OTLK|Net earnings per share for the last four quarters Clearside Biomedical, Inc. (CLSD)|NBY - Earnings per share for the last twelve months|Earnings per share for the trailing year ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Corp) - Net earnings per share for the last 12 months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters